Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13G with respect to the securities beneficially owned by each of them of Orchard Therapeutics plc. This Joint Filing Agreement shall be included as an Exhibit to such Schedule 13G.
Dated: November 12, 2018 | TEMASEK HOLDINGS (PRIVATE) LIMITED | |||||||
By: | /s/ Andrew Ang Lye Whatt | |||||||
Name | : | Andrew Ang Lye Whatt | ||||||
Title | : | Authorized Signatory | ||||||
Dated: November 12, 2018 | FULLERTON MANAGEMENT PTE LTD | |||||||
By: | /s/ Cheong Kok Tim | |||||||
Name | : | Cheong Kok Tim | ||||||
Title | : | Director | ||||||
Dated: November 12, 2018 | TEMASEK LIFE SCIENCES PRIVATE LIMITED | |||||||
By: | /s/ Lim Siew Lee Sherlyn | |||||||
Name | : | Lim Siew Lee Sherlyn | ||||||
Title | : | Director |